Supporting investment into the region and companies to find funding opportunities

Open funding calls

Tackling disease with healthcare innovations

There is up to £12 million to support projects that are developing or testing out new healthcare products, technologies or processes.

This funding is available through the Biomedical Catalyst, a partnership between Innovate UK and the Medical Research Council that supports innovative opportunities in the life sciences.

Projects in the Biomedical Catalyst could:

  • help to prevent or manage chronic conditions
  • lead to better detection or diagnosis of disease
  • that treat disease or offer potential cures

In this funding round there are 2 competitions.

Late stage projects

Up to £8 million is available for late-stage projects that test a well-developed concept and demonstrate its suitability in a relevant environment.

A late-stage project can include:

  • initial human proof-of-concept studies
  • demonstration of clinical utility and effectiveness
  • demonstration of safety and efficacy. This includes phase I and II clinical trials
  • developing production mechanisms
  • prototyping
  • market testing
  • intellectual property protection

Primer awards

A further £4 million is available in primer awards. This is for projects that carry out technical evaluations through to proofs of concept in a model system.

A primer project could include:

  • experimental evaluation done at laboratory scale
  • initial demonstration using in vitro and in vivo models. It does not include human clinical trials such as safety or efficacy
  • exploring potential production mechanisms
  • early-stage prototyping
  • product development planning
  • intellectual property protection

Competition information

  • projects must be led by an SME, working alone or with other SMEs or research organisations
  • we expect projects to range in size from £200,000 to £1.5 million and to last between 1 and 2 years
  • businesses could attract up to 70% of their project costs

Further details can be found here

Deadline date: 7 February 2018

Support for SMEs to evaluate innovative medical technologies

The Office for Life Sciences (OLS) in partnership with Innovate UK is to invest up to £1 million to support developers of innovative medicines, medical devices, diagnostics and regulated digital technology to evaluate their product in a real world clinical setting.

This competition aims to provide support for small and medium-sized enterprises (SMEs) to generate an evidence base that will enable the evaluation of products that address NHS priorities. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting.

Proposals should:

  • describe the innovative medicine or CE-marked device
  • include any current up to date evidence of the product’s clinical performance and cost effectiveness
  • demonstrate how the product meets the priority needs defined in next steps on the NHS 5 year forward view, and how it is expected to deliver significant cost savings, health gains or beneficial service impacts, if quickly adopted across NHS England
  • provide evidence that you are working with appropriate stakeholders including the National Institute for Health and Care Excellence (NICE), NHS England, National Institute of Health Research (NIHR) and Academic Health Science Networks (AHSNs)
  • include the development or implementation of plans for data collection within the NHS
  • outline how studies will generate data on the costs and benefits of a product, allowing evaluation by NICE

All projects must be business led.

Collaborative partners are permitted but not required. Only the lead partner can claim grant.

Total project costs must range in size from £50,000 to £250,000. Projects must start by 1 June 2018 and be completed by the end of March 2019.

Further details can be found here

Open date: Monday 29 January 2018
Deadline date: Noon Wednesday 21 March 2018

January 2018 sector competition: strand 1, health and life sciences

Innovate UK will invest in a share of up to £19 million in innovation projects that inspire new products, processes and services. These should address challenges in health and life sciences (H&LS).

A further £12 million is available to fund Knowledge Transfer Partnerships (KTPs).

Projects must show significant innovation in one of our priority areas:

  • increasing agricultural productivity
  • improving food quality and sustainability
  • advanced therapies (cell and gene therapies)
  • precision medicine
  • medicines discovery
  • advanced biosciences

This competition has 2 strands. This is the health and life sciences strand. The other strand is emerging and enabling.

Proposals must show how projects will enable a significant change in competitiveness and productivity for at least one UK SME involved in the project.

Your project’s total costs should be between £50,000 and £2 million. Projects should last between 6 months and 24 months. Projects lasting up to 12 months should start by August 2018, and projects up to 24 months should start by December 2018.

Further details can be found here

Open date: Monday 22 January
Deadline date: Noon Wednesday 28 March 2018

Digital health technology catalyst round 2

Funded through the Industrial Strategy Challenge Fund, the Digital Health Technology Catalyst (DHTC) is a £35 million fund, being run over 4 years.

The DHTC is an important element of the government’s plans to implement the Accelerated Access Review (AAR). It aims to address some of the challenges that the review identified around the development of digital health innovations, and to help grow the digital health sector.

Innovate UK is to invest up to £8 million in DHTC round 2 for industrial research and experimental development projects. Projects should develop new commercial digital technology solutions to address significant healthcare challenges.

An SME must lead the project in collaboration with at least one other grant-claiming partner.

Your project’s total costs should be between £300,000 and £1 million. Projects should start by August 2018 and last up to a maximum of 30 months.

Further details can be found here

Open date: Thursday 15 February 2018
Deadline date: Noon Wednesday 18 April 2018

Contact: Ashley Aitken

Ashley Aitken
Project Manager, Diagnostics

Ashley has experience of sales and marketing in the life science sector. She is a graduate of the University of Warwick, and specialised in Molecular Genetics.
Email Ashley

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image